Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study

摘要

BackgroundSince warfarin is primarily bound to serum albumin, hypoalbuminemia is likely to increase the free fraction of warfarin and to increase the risk of bleeding. We prospectively evaluated the impact of serum albumin levels (ALB) on international normalized ratio of prothrombin time (PT-INR) control and hemorrhagic events in atrial fibrillation (AF) patients treated with warfarin.MethodsSeven hundred fifty-five non-valvular AF patients on warfarin were enrolled. PT-INR control and major bleeding events (MB, International Society on Thrombosis and Haemostasis) were prospectively followed and were related to ALB at enrollment.ResultsTwenty-seven patients developed MB during 1-year follow-up. In univariate/multivariate analyses, ALB (OR?=?0.49, 95% CI 0.26–0.99, p?=?0.04) and hemoglobin levels (OR?=?0.78, 95% CI 0.65–0.92, p?=??3.0 (ρ?=??0.15, p?